• New Steerable Catheter Targets Cardiac Arrhythmia

    The new catheter technology, developed in the U.K., enables targeted delivery of radio frequency energy to specific points in heart tissue.Kristopher SturgisResearchers at  King’s College in London and the Cambridge Design Partnership (CDP) have developed a novel treatment for cardiac arrhythmia.Kawal Rhode, professor of biomedical engineering at King’s College and one of the lead researchers on the project, says this new device is unlike any conventional catheter technology because of its...
  • Is UDI a Big Problem for Medtech?

    A new poll of medical device professionals suggests it is. Chris NewmarkerOnly 15% of medical device industry professionals helping to implement FDA’s Unique Device Identification rule say their companies are ready for upcoming compliance deadlines, according to a report released this month by enterprise labeling services company Loftware (Portsmouth, NH) and professional services firm USDM Life Sciences (Santa Barbara, CA).The two companies' poll involved 120 medtech...
  • Why Manufacturing Execution Systems Matter More Than Ever in Medtech

    Think higher quality products, completely compliant to regulations, for a fraction of the cost. John Dzelme, Seabrook Technology GroupThe concept of Industry 4.0 is quickly gathering weight across the manufacturing industry, as the reality of its onset becomes imminent. This new era, which follows on from the third industrial revolution of automation, will bring the “Internet of Things” and advanced technologies to the world of manufacturing, leading to unprecedented precision and efficiency...
  • Boston Sci Has a Major Lotus Valve Recall

    In announcing a global recall of the TAVR valve, Boston Sci said there were three patient deaths related to a flawed delivery system component. Chris Newmarker Boston Scientific is recalling any Lotus transcatheter aortic valve replacement systems made before March 2016 that have not been implanted, according to a notice to health providers posted on the website of Germany's Federal Institute for Drugs and Medical Devices. Learn what it will take to design the next generation of...
  • Unlocking the Mysteries of Rechargeable Batteries

    Stanford University researchers are seeking a new fundamental understanding of how particles charge and discharge at the nanoscale level. Their work could lead to a new generation of lithium-ion battery design.Kristopher SturgisThis artistic rendering show lithium-ion battery particles illuminated by a finely focused x-ray beam. (Image courtesy of Chueh Lab at Stanford University)It is actually possible to observe the electrochemical reactions that fuel lithium-ion batteries, the most...
  • How Lasers Are Boosting Glass Microfabrication

    They’re enabling further advances in MEMS and microfluidic diagnostic applications.Glenn Ogura, ResoneticsBorosilicate or its tempered trademarked version “PYREX” is widely used in MEMs and microfluidic diagnostic applications. (Although fused silica, which is formed by pure silica, without the addition of metal oxides, has superior optical transmission, it is much more expensive than borosilicate glass owing to more complex processing requirements associated with its very high...
  • This Reanimated Heart Footage Is Amazing

    The reanimation allows for visualization of the unique functional anatomies within each heart, explains the University of Minnesota's Paul Iaizzo. Chris Newmarker This living pig heart is hooked up on equipment to keep it beating at the University of Minnesota's Visible Heart Lab. Such equipment has also been used to reanimate 70 human hearts over the past 17 years. (Image courtesy of Visible Heart Lab)Watch enough Frankenstein movies, and you'll probably get excited about the idea of...
  • Theranos CEO Can't Catch a Break

    CEO Elizabeth Holmes has stepped down as an entrepreneurial ambassador for the Obama administration.Chris NewmarkerTheranos CEO Elizabeth Holmes and Vice President Joe Biden spoke on the importance of preventive medicine at a press event last year at the compamy's Newark, CA lab, which later ran afoul of CMS. (Image courtesy of Theranos)When will things ever get better for Theranos CEO Elizabeth Holmes? Her company acknowledged Wednesday that she was stepping down as an...
  • Medtech's Top Young Innovators

    They’re behind innovations in mobile health, diagnostics, exoskeletons, and much more. Meet the medical technology field’s rising stars.Qmed StaffOmron Blauo, 25, started Telescrypts because he wanted people in developing countries to have access to wearable healthcare technology that was both quality but inexpensive. Samantha Huynh, 27, is designing an exoskeleton that reads the wearer's own muscle signals. She's a biomedical engineering PhD student at the University of Southern...
  • 3-D Bioprinting Is Heading to Space

    Russia’s space program reportedly wants to get a magnetic, zero-gravity, 3-D bioprinter onboard the International Space Station by 2018.Chris NewmarkerRussia's state-run United Rocket and Space Corp. (Roscosmos) has inked a deal with a company called 3D Bioprinting Solutions to create a bioprinter able to operate in the weightless environment of space. 9 Eye-Opening Facts about NASA's Medical TechnologyThe goal is to have a bioprinter ready for delivery to the International...
  • Was Theranos CEO Smart to Speak at Conference?

    Elizabeth Holmes reportedly continued to deflect blame during her appearance at a Philadelphia conference, and she had a tough time with CNN’s Sanjay Gupta, too. Chris NewmarkerTheranos CEO Elizabeth Holmes is attempting to turn a corner with her troubled Silicon Valley blood testing company: more data, more public appearances, more interviews. It has also resulted in more trouble, apparently. In a Monday appearance at the American Association for Clinical Chemistry annual...
  • IBM Touts Lab-on-a-Chip Breakthrough

    The high tech giant’s scientists say the technology is able to separate biological particles at the nanoscale. Chris NewmarkerA new lab-on-a-chip developed at IBM could potentially allow physicians to detect diseases such as cancer before symptoms appear, the high tech giant announced this week. Tests of the chip, reported in the journal Nature Nanotechnology, show the chip separating biological particles at the nanoscale level. Separation of bioparticles took place down to the scale...
  • Gore's Highly Flexible Vascular Stent Wins FDA Approval

    The third-generation stent is designed for high conformability, making it ideal for peripheral artery disease cases in more complex anatomies.Marie ThibaultW.L. Gore & Associates announced on Tuesday that its TIGRIS Vascular Stent has earned FDA approval. The stent, used to treat peripheral artery disease (PAD), had a zero fracture rate in its U.S. clinical study. This means it is well-suited to withstand the flexion, torsion, compression, and extension encountered in the superficial...
  • New Philips Mobile Health Devices Hit the Market

    The medical-grade health monitoring devices connect to Philips’s HealthSuite Health App and cloud-based analytics. Chris NewmarkerPhilips devices hitting the market on August 1 include (clockwise from top left) a health watch, eart thermometer, upper arm blood pressure analyzer, and body analysis scale. (Images courtesy of Philips)Royal Philips on Monday announced worldwide availability of a host of health monitoring devices as the Dutch multinational continues to make a major push to expand in...
  • Google's Verily Bets Big on Bioelectronics

    Verily and GlaxoSmithKline plan to spend up to $712 million over the next seven years on a new U.K.-based venture called Galvani Bioelectronics. Chris Newmarker GlaxoSmithKline and Google's fellow Alphabet company Verily Life Sciences on Monday announced the formation of Galvani Bioelectronics, a new U.K.-headquartered company that will pioneer tiny bioelectronic devices to treat a wide range of chronic diseases.GSK will own a 55% equity interest in Galvani, and Verily will own 45%. An...
  • What Does Neurology Group's Recommendation on PFO Closure Mean for St. Jude?

     The American Academy of Neurology has recommended against percutaneous closure of a congenital heart defect in patients who have had a stroke just as St. Jude Medical anticipates a device to treat the condition will gain FDA approval.Nancy CrottiSt. Jude Medical doesn’t even have FDA approval yet for a device purported to prevent stroke, and a major physicians’ group is warning against implanting it in stroke survivors.Learn what it takes to innovate in the structural heart space at the...
  • Theranos CEO Courts Controversy at Clinical Chemistry Meeting

    Elizabeth Holmes will explain Theranos’s testing methodology at the American Association for Clinical Chemistry annual meeting, but some question the decision to give her a podium.Nancy CrottiThe founder and CEO of secretive and embattled Theranos is scheduled to discuss the science behind the company’s proprietary blood-testing technology at a prestigious clinical laboratory conference in Philadelphia on Monday.Network with your medtech colleagues at MD&M Minneapolis, September 21...
  • How Can OEMs Respond to the Threat of Medical Device Hacks?

    Wireless protocols and standards are urgently needed to protect medical devices from data infringement.Mike KanisCybersecurity is a critical issue for individuals, businesses, industries, and entire nations these days, and data vulnerability is alarmingly real. Breaches of every scale are reported in the news on a regular basis, usually tied to financial information stored by retailers and banks. The world is going digital in all aspects of modern life, from banking to social networking,...
  • EndoStim Inc.

         EndoStim Inc., based in St. Louis, MO, and The Hague, The Netherlands, has developed a laparoscopically implanted stimulation system that delivers electrical impulses to treat gastroesophageal reflux disease. In May, the company secured $25 million in venture funding that will help it conduct a pivotal U.S. clinical trial.Continue >>Don't miss the MD&M Minneapolis conference and expo, September 21–22, 2016.[image courtesy of the company]
  • OptiScan Biomedical Inc.

         OptiScan Biomedical’s OptiScanner 5000 bedside blood monitoring system automates monitoring of patients’ plasma glucose levels in the intensive care unit, and the company is expanding its platform to measure hemoglobin and central venous oxygen saturation levels. Monitoring these metrics can provide early warning when a critically ill patient’s condition goes downhill. The OptiScanner 5000 has been sold in Europe since 2014. OptiScan Biomedical nabbed $29.5 million in...